Rare strain of disease confirmed in Australia for just the second time
A case of the Clade 1 strain of mpox has been confirmed in a patient in Queensland 's Metro South Hospital and Health Service region, the state's health body said.
The patient is believed to have acquired mpox overseas before arriving in Australia, state Health Minister Tim Nicholls said.
'Contact tracing has been occurring, and the community can be assured that exposure to members of the community has been very limited, and the public should not be concerned,' he said on Saturday.
The detection is the second incidence of the mpox strain reported in Australia after a returned traveller tested positive for the virus in NSW in May.
Mpox is a viral infection that typically displays mild symptoms of fever, headache, muscle aches, swollen lymph nodes or fatigue, followed by a skin rash or lesions.
The disease does not easily spread between people and mostly occurs through very close or intimate contact with someone infected.
Groups at higher risk of infection include sexually active gay, bisexual or other men who have sex with men and their partners.
Health authorities say vaccinations for pre- and post-exposure to the disease are effective and are available for free through sexual health clinics and general practitioners.
The World Health Organization declared the mpox outbreak a public health emergency of international concern in August 2024.
The disease was first detected in Australia in 2022, with the number of cases spiking to more than 1400 in 2024, according to Australia's National Notifiable Disease Surveillance System.
There have been about 150 confirmed cases of mpox in 2025.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
3 hours ago
- Daily Mail
Erin is a gentle and beloved single mum in Melbourne. She's just been diagnosed with Alzheimer's at 29
At just 29, Melbourne mum Erin Kelly is facing the heartbreaking reality that she's living on borrowed time. A single parent to her eight-year-old daughter Evie, Erin has recently been diagnosed with early onset Alzheimer's - a devastating blow made even more cruel by its rare genetic cause. Now she's in a race against the clock to fund the one treatment that could slow it down. 'There's no chance of me reaching retirement age so I'm doing everything I can now, while I still can,' Erin told the Daily Mail. Alzheimer's typically strikes later in life, but for Erin, it's deeply personal, and terrifyingly genetic. In May 2024, the young mum discovered she carries a rare mutation of the PSEN1 gene, one that guarantees she will develop Alzheimer's earlier than normal. Only about 200 families worldwide carry it. 'With young onset Alzheimer's, they (the specialists) said only 1 per cent of young onset Alzheimer's cases are caused by a genetic mutation,' Erin said. 'I always knew there was a 50/50 chance I'd develop it later in life. But even with my family history, I never imagined it would happen to me this early.' Erin lost her mum to Alzheimer's when she was just 17. Her mum was only 50. After further digging, she's now found out that eight members of her extended family have battled the disease too. However, the PSEN1 mutation is what makes Erin's diagnosis so rare and so aggressive. Doctors can't say much without more tests, but have told Erin that her life expectacny is between another eight to 15 years. The official diagnosis came in July, following a year-long journey of MRIs, specialist consultations and anxious waiting. It was Erin's father who first urged her to get tested for the mutation in May 2024, after she began noticing small lapses and mixed-up words, which she initially dismissed. 'A year ago I contacted Alzheimer's Australia, but they originally said they couldn't help because I didn't have a confirmed diagnosis yet,' she said. 'So, I reached out to many others including neurologists, and they all said they didn't really know what to do with me. But then I ended up with a geriatrician [a doctor specialising in the care of the elderly], and he is helping.' Despite early symptoms and a clear family history, getting answers has been slow and costly. Specialists charged up to $500 a visit. Each scan costs her hundreds more. She has since been referred to a neuropsychologist, speech therapist and dietitian - but couldn't afford to see any of them. Even a medical drink called Souvenaid, formulated to support memory in Alzheimer's patients, was too expensive at $100 a month. 'I've had to pick and choose what I can pay for. I just can't justify that as well, given the position we're in,' she said. Despite her diagnosis, Erin was told she is too young to qualify for Australian clinical trials or subsidised treatment. 'It's like they don't know what to do with me,' she said. But there is a treatment that could help, which is a breakthrough infusion drug called Leqembi. Leqembi, which is administered as an infusion every two weeks, has been shown to slow the progression of Alzheimer's by up to 30 per cent. It works by targeting and removing the sticky amyloid plaques that kill brain cells and cause cognitive decline. There's just one problem - it's only available on a case-by-case basis for people aged 50 to 90, and at a staggering cost of $90,000. 'My doctor basically said that I don't cover a lot of the criteria. But if I can supply the money, then I've got a much higher chance of being accepted,' she said. Since Evie was six weeks old, it's been just the two of them. Erin has poured every ounce of her energy into raising her daughter and building a stable life. Now, she's fighting to hold onto that life and the precious time she has left. She's started creating photo books and writing letters for Evie, capturing memories and family stories she fears she won't be able to tell one day. 'I want her to remember who I was. Who her grandmother was, too, as I'm the only one who can tell her that,' she said. A breakthrough infusion drug called Leqembi could delay Erin's symptoms by up to 30 per cent, but she is too young to qualify for it - unless she can pay $90,000 Erin's family hopes to raise the full $90,000 to cover ongoing treatments and give her a fighting chance at slowing the disease in its tracks. If treatment becomes impossible, the funds will help create lasting memories with Evie too, as well as special time together, and the chance to simply live while she still can. 'She's not asking for a miracle,' her stepsister Jessica said. 'She's just asking for more time.'
The Guardian
3 hours ago
- The Guardian
Sir David Nabarro obituary
Many young people start out wanting to make a difference. Sir David Nabarro, who has died aged 75, was unusual in recognising early on the power of synergy. Aged 17, he was the subject of a 1967 BBC documentary on volunteering when he spent a year as organiser of Youth Action, leading a group of 400 volunteers in York, between leaving Oundle public school and going to Oxford University to study medicine. That experience – coordinating efforts for maximum impact – presaged a life in public service spent urging, cajoling and commanding others to work together. After stints as a medical officer in Iraq and Nepal, and as a health and population adviser in Kenya, he joined the World Health Organization, and subsequently the UN, leading the responses to the 2004 Indian ocean tsunami, the 2014 Ebola outbreak in West Africa and the 2016 cholera outbreak in Haiti. But it was as the WHO's special envoy for Covid-19, one of six appointed by the director general, that Nabarro became best known in the UK. He described the pandemic as a 'health crisis unlike anything we have encountered in my professional experience'. He was early to advocate the use of masks and testing, tracing and isolating infected individuals, but courted controversy with his remarks on lockdowns – which he said were misquoted. He argued that lockdowns should be used as 'circuit breakers', as a reserve measure to temporarily slow the spread of the virus, buying time and allowing the NHS and similar institutions to reorganise, regroup and rebalance their resources and protect their workers. In an interview with BBC Radio 4 in 2020 he cautioned against a full national lockdown, describing it as a 'a very extreme restriction on economic and social life' that temporarily 'freezes the virus in place'. He added: 'You don't want to use those as your primary, and I stress primary, means of containment. Because in the end living with the virus as a constant threat means maintaining the capacity to find people with the disease and isolating them.' The primary measure, he thought, should be a robust test, trace and isolate system, with lockdown 'the reserve you use to take the heat out of the system when things are really bad'. As a lifelong champion of health equity, he was critical of the global response to the pandemic. He lamented the way that politics had begun shifting how governments responded to global health emergencies. In a 2021 interview with NPR, the US public radio network, he recalled how the global response to Ebola in 2014 had been 'amazing', but that by the time Covid-19 developed in 2020 things had changed. 'There has been a funny shift,' he said. 'I find world leaders are no longer apparently able to work together and deal with this through a global response.' Despite his disappointment he worked tirelessly to protect the UK and beyond from the pandemic, arguing forcefully for vaccine equity. 'The one thing we want [at the WHO] is every country in the world to be able to access a fair share of the vaccine,' he said. He was knighted in 2023. His kindness, humility and decency won loyalty from staff, though his work ethic could be challenging. He was the 'Gandalf of the UN', said Aurélia Nguyen of the Coalition for Epidemic Preparedness Innovations. He was 'always working behind the scenes for a broader purpose in ways that were not visible or needing to take credit but quietly bringing people to the table who otherwise would not speak to each other. He worked all hours relentlessly – some of his staff may say mercilessly – but with such conviction and passion it was impossible not to follow him.' Born in London, David was one of the four children of Sir John Nabarro, a consultant endocrinologist, and Joan (nee Cockrell). David was educated at Oundle school, Northamptonshire, before studying medicine at Worcester College, Oxford, and University College hospital, London. He joined WHO in 1999, working first on malaria and later, alongside the director-general Gro Harlem Brundtland on the creation of the global fund to fight Aids, tuberculosis and malaria, which has since saved millions of lives. In 2003 he survived the bombing of the Canal hotel in Baghdad while serving as WHO representative for health action in crises. He was appointed senior UN system coordinator for avian influenza (bird flu) in 2005, establishing him as a pioneer in pandemic preparedness. His most visible role on the international stage came in 2014 when he coordinated an unprecedented response to the Ebola outbreak in West Africa. Facing a situation where 'the number of people getting sick was doubling every week', he helped bring the epidemic under control by engaging the community, building trust and addressing social and economic factors alongside delivering medical aid. Championing the synergy between social and medical interventions stands as the legacy of his lifetime of service. In 2019 he became co-director, with me, of the Institute of Global Health Innovation at Imperial College London, a role to which he brought his vast operational experience, remarkable ability to build consensus among diverse stakeholders, and readiness to mentor young researchers. His office was always open to students and colleagues seeking guidance, and his generous spirit enriched the academic community. Nabarro is survived by his second wife, Florence Lasbennes, whom he married in 2019, and by five children – two sons and a daughter from a relationship with Susanna Graham-Jones, and a daughter and son from his marriage to Gillian Holmes, which ended in divorce – and seven grandchildren. David Nunes Nabarro, global health strategist, born 26 August 1949; died 26 July 2025
BBC News
5 hours ago
- BBC News
Kent and Medway public health leaders urge uptake of MMR vaccine
Public health leaders in Kent and Medway have urged parents and carers to help children catch up on measles, mumps and rubella (MMR) while easily spread and potentially dangerous, is preventable with two doses of the MMR 2023/24, 84% of five-year-olds in Kent had both doses of MMR while the proportion for Medway was 80% - down from 86% and 82% this was only a slight dip on the previous year, Kent County Council's director of public health, Dr Anjan Ghosh, said "any drop off in protection is concerning". He said: "Now, fewer children are getting protected and this highly infectious disease is back, with over 500 confirmed cases in England since the start of the year."While Dr Ghosh acknowledged that "Kent and Medway's vaccine rates remain higher than some", they still fall short of the 95% recommendation from the part of national changes to immunisations to boost uptake, from 1 January next year, children born on or after 1 July 2024 will be offered the second MMR dose at a new 18-month appointment.
